With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s FARXIGA ® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dr. Roach: My question is: What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback